Scott MacLeod's Anthropology of Information Technology & Counterculture

Bulbophyllum spp: Twitter - #AIprofs are negotiating .new realities of academic research | #MITTechReview * * * [Air-L] CFP: AoIR CDMX Preconference: In Defense of the Commons ~ Did you or any of you see this GREAT Creative Commons' Fireside Chat with its Founders * * * Stanford Medicine - ENT Experts Up Close- Latest Advances in Rhinology and Sinus Surgery, Tue August 11, 2026 * * * What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different? What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different? https://share.gemini.google/pxEACRi58KBE What are around five next likely OSK aging reversal gene drug therapies likely to go through clinical trials related to the ER 100 drug for glaucoma conditions, epigenetic reprogramming, but somehow also quite different from ER 100. What are the five next possible or likely OSK drugs to enter clinical trials? Turn Biotechnologies' ERA platform uses mRNA and lipid nanoparticles to transiently deliver reprogramming factors for skin and immune rejuvenation without using viral vectors. Rejuvenate Bio injects systemic AAV-based OSK therapies into the bloodstream to reverse widespread age-related diseases like heart failure and whole-body frailty. Retro Biosciences directs AAV-delivered epigenetic reprogramming factors into highly specific peripheral tissues to treat osteoarthritis and age-related hearing loss. Altos Labs engineers customized transcription factors and small-molecule alternatives to standard OSK to treat broad metabolic and neurodegenerative conditions. Ex vivo cellular reprogramming extracts patient cells, resets their epigenome safely in a lab environment, and reinfuses them to cure blood or brain disorders. https://share.gemini.google/pxEACRi58KBE * * * Claudia, Thanks - at MIT - for connecting on LinkedIN Tu 8/11/26 & greetings from World Univ & Sch building on MIT OCW in 7 languages +

Twitter - #AIprofs are negotiating .new realities of academic research | #MITTechReview #AIprofs are negotiating .new realities of academic ...